Trends in Ambulatory Prescribing of Antiplatelet Therapy among US Ischemic Stroke Patients: 2000–2007

<table>Antiplatelet prescribing trends among patients with ischemic stroke: NAMCS, NHAMCS, 2000–2007. NAMCS: National Ambulatory Medical Care Survey; NHAMCS: National Hospital Ambulatory Medical Care Survey; <svg height="11.175" id="M23" style="vertical-align:-0.0pt" version="1.1" viewbox="0 0 10.9375 11.175" width="10.9375" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,11.113)"><path d="M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5
t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z" id="x1D443"></path></g>
</svg> values based on Cochran-Mantel-Haenszel test for trend. Years of publication of the 3 clinical trials shown in the figure above: 2001—CURE (Clopidogrel in Unstable Angina to Prevent Recurrent Events trial); 2002—CREDO (Clopidogrel for the Reduction of Events During Observation); 2004—MATCH (Management of ATherothrombosis with Clopidogrel in High-risk patients).</table>

Advances in Pharmacological and Pharmaceutical Sciences

fig1

Figure 1

Figure 1: Trends in Ambulatory Prescribing of Antiplatelet Therapy among US Ischemic Stroke Patients: 2000–2007 